---
figid: PMC4450766__MOL2-8-1339-g005
figtitle: EGFR pathway and the model of the effect of EGFR/MEK/EGFR + MEK inhibition
  on the pathway in RAS‐active NSCLC cell lines
organisms:
- Homo sapiens
pmcid: PMC4450766
filename: MOL2-8-1339-g005.jpg
figlink: /pmc/articles/PMC4450766/figure/mol22014871339-fig-0005/
number: F5
caption: The EGFR pathway and the model of the effect of EGFR/MEK/EGFR + MEK inhibition
  on the pathway in RAS‐active NSCLC cell lines. EGFR monotherapy inhibits activation
  of EGFR, KRAS and AKT (blue), while U0126 inhibits the activity of MEK, preventing
  the activation of ERK (red). Combined therapy leads to the inhibition of all the
  aforementioned proteins (blue and red) plus RPS6 and RAF1 (purple), which are also
  degraded.
papertitle: Genomic classification of the RAS network identifies a personalized treatment
  strategy for lung cancer.
reftext: Nader N. El-Chaar, et al. Mol Oncol. 2014 Oct;8(7):1339-1354.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9185998
figid_alias: PMC4450766__F5
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC4450766__F5
ndex: 1bbd01e7-df0a-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4450766__MOL2-8-1339-g005.html
  '@type': Dataset
  description: The EGFR pathway and the model of the effect of EGFR/MEK/EGFR + MEK
    inhibition on the pathway in RAS‐active NSCLC cell lines. EGFR monotherapy inhibits
    activation of EGFR, KRAS and AKT (blue), while U0126 inhibits the activity of
    MEK, preventing the activation of ERK (red). Combined therapy leads to the inhibition
    of all the aforementioned proteins (blue and red) plus RPS6 and RAF1 (purple),
    which are also degraded.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - NRAS
  - RAF1
  - RNASE3
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - RPS6
  - U0126
  - Cancer
  - Noonan syndrome
---
